683 Capital Management »

Avalo Therapeutics Ord shares owned by 683 Capital Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.0M 57k 18.16

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Avalo Therapeutics Ord

BVF
Nantahala Capital Management
OrbiMed Advisors
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Vanguard Group
RA Capital Management
Point72 Asset Management
Silverarc Capital Management
Marshall Wace
Citadel Advisors
Commodore Capital
TCG Crossover Management
UBS Group

View all funds holding Avalo Therapeutics Ord